Abstract
The concentration of NS-3 (montirelin hydrate, CG 3703), a thyrotropin-releasing hormone (TRH) analogue, in the cerebral cortex of urethane-anaesthetized rats was measured after its systemic administration (1 mg kg-1, i.v.), using in-vivo microdialysis coupled with a radioimmunoassay. The concentration in microdialysates was highest (24 nM) during the first 20 min after injection, and it fell below the detection limit (3.5 nM) 100 min after treatment. The maximal interstitial concentration was estimated to be 0.51 microM. From these results, it is suggested that NS-3 can readily penetrate into the brain.
References
Mar 29, 1979·Nature·P W Kalivas, A Horita
Oct 29, 1979·Life Sciences·J E Morley
Sep 17, 1976·Psychopharmacology·L KorányiJ Borsy
Jul 1, 1977·Neuropharmacology·J S BealeS P Huang
Dec 1, 1975·European Journal of Pharmacology·T HökfeltN White
Aug 1, 1991·Journal of Pharmacobio-dynamics·Y DeguchiA Tsuji
Jan 1, 1990·Journal of Neurochemistry·G O'CuinnM Elmore
Jan 1, 1990·Endocrinology·A O DonosoA Negro-Vilar
Jun 1, 1989·Journal of Neurochemistry·H Benveniste
Jun 1, 1989·Journal of Neurochemistry·H BenvenisteN S Ottosen
Jan 1, 1986·Annual Review of Pharmacology and Toxicology·A HoritaH Lai
Apr 1, 1987·Neuropharmacology·D J HealM B Youdim
Aug 17, 1987·Life Sciences·U Ungerstedt, A Hallström
Nov 1, 1985·Journal of Neurochemistry·A PazosJ M Palacios
Aug 1, 1974·Endocrinology·C OliverJ C Porter
Nov 1, 1966·Journal of Neurochemistry·L BitoN Snider
Jan 7, 1982·Brain Research·M Del FiaccoA C Cuello
Dec 1, 1983·Neuroscience·M M MesulamA I Levey
Jul 11, 1983·Life Sciences·G G Yarbrough
Sep 1, 1984·Endocrinology·M SafranC H Emerson
Citations
Jan 1, 1997·Life Sciences·Y ItohK Kimura
Jun 1, 1996·Pharmacology & Toxicology·Y ItohK Kimura
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Akihiko UrayamaRyohei Kimura
May 28, 2020·Frontiers in Pharmacology·Jean-Louis CharliPatricia Joseph-Bravo